Flores, Eduardo P.
HRN: 21-52-67 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/06/2022
CEFTRIAXONE 1G (VIAL)
07/06/2022
07/15/2022
IVT
2g
OD
Fungating Mass R Gluteal Area With Multiple Fistula
Waiting Final Action
Indication: Empiric Type of Infection: BloodstreamSkin & Soft Tissue Compliance to guidelines: Guideline Not Available
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes